Literature DB >> 23124940

Cardiac metabolism in hypertrophy and heart failure: implications for therapy.

N Siddiqi1, S Singh, R Beadle, D Dawson, M Frenneaux.   

Abstract

The heart consumes huge amounts of energy to fulfil its function as a relentless pump. A highly sophisticated system of energy generation based on flexibility of substrate use and efficient energy production, effective energy sensing and energy transfer ensures function of the healthy heart across a range of physiological situations. In left ventricular hypertrophy and heart failure, these processes become disturbed, leading as will be discussed to impaired cardiac energetic status and to further impairment of cardiac function. These metabolic disturbances form a potential target for therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23124940     DOI: 10.1007/s10741-012-9359-2

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  98 in total

Review 1.  Metabolic control through the PGC-1 family of transcription coactivators.

Authors:  Jiandie Lin; Christoph Handschin; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

2.  Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure.

Authors:  George G Sokos; Lazaros A Nikolaidis; Sunil Mankad; Dariush Elahi; Richard P Shannon
Journal:  J Card Fail       Date:  2006-12       Impact factor: 5.712

3.  Allopurinol acutely increases adenosine triphospate energy delivery in failing human hearts.

Authors:  Glenn A Hirsch; Paul A Bottomley; Gary Gerstenblith; Robert G Weiss
Journal:  J Am Coll Cardiol       Date:  2012-02-28       Impact factor: 24.094

Review 4.  The PPAR regulatory system in cardiac physiology and disease.

Authors:  Brian N Finck
Journal:  Cardiovasc Res       Date:  2006-09-01       Impact factor: 10.787

5.  Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure.

Authors:  T R Wallhaus; M Taylor; T R DeGrado; D C Russell; P Stanko; R J Nickles; C K Stone
Journal:  Circulation       Date:  2001-05-22       Impact factor: 29.690

6.  Cyclosporine A attenuates mitochondrial permeability transition and improves mitochondrial respiratory function in cardiomyocytes isolated from dogs with heart failure.

Authors:  Victor G Sharov; Anastassia Todor; Sanjaya Khanal; Makoto Imai; Hani N Sabbah
Journal:  J Mol Cell Cardiol       Date:  2006-10-27       Impact factor: 5.000

7.  On the inability of ketone bodies to serve as the only energy providing substrate for rat heart at physiological work load.

Authors:  H Taegtmeyer
Journal:  Basic Res Cardiol       Date:  1983 Jul-Aug       Impact factor: 17.165

8.  Enhancing mitochondrial Ca2+ uptake in myocytes from failing hearts restores energy supply and demand matching.

Authors:  Ting Liu; Brian O'Rourke
Journal:  Circ Res       Date:  2008-07-03       Impact factor: 17.367

Review 9.  Metabolic mechanisms in heart failure.

Authors:  Houman Ashrafian; Michael P Frenneaux; Lionel H Opie
Journal:  Circulation       Date:  2007-07-24       Impact factor: 29.690

10.  Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog.

Authors:  F A Recchia; P I McConnell; R D Bernstein; T R Vogel; X Xu; T H Hintze
Journal:  Circ Res       Date:  1998-11-16       Impact factor: 17.367

View more
  8 in total

1.  Metabolomic analysis of serum and myocardium in compensated heart failure after myocardial infarction.

Authors:  M Dan McKirnan; Yasuhiro Ichikawa; Zheng Zhang; Alice E Zemljic-Harpf; Sili Fan; Dinesh Kumar Barupal; Hemal H Patel; H Kirk Hammond; David M Roth
Journal:  Life Sci       Date:  2019-02-05       Impact factor: 5.037

2.  Mitochondrial dysfunction and its impact on diabetic heart.

Authors:  Suresh Kumar Verma; Venkata Naga Srikanth Garikipati; Raj Kishore
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-09-01       Impact factor: 5.187

Review 3.  Altered myocardial calcium cycling and energetics in heart failure--a rational approach for disease treatment.

Authors:  Przemek A Gorski; Delaine K Ceholski; Roger J Hajjar
Journal:  Cell Metab       Date:  2015-02-03       Impact factor: 27.287

4.  Changes in short-chain acyl-coA dehydrogenase during rat cardiac development and stress.

Authors:  Jinxian Huang; Lipeng Xu; Qiuju Huang; Jiani Luo; Peiqing Liu; Shaorui Chen; Xi Yuan; Yao Lu; Ping Wang; Sigui Zhou
Journal:  J Cell Mol Med       Date:  2015-03-08       Impact factor: 5.310

5.  QiShenYiQi Pills, a compound in Chinese medicine, protects against pressure overload-induced cardiac hypertrophy through a multi-component and multi-target mode.

Authors:  Yuan-Yuan Chen; Quan Li; Chun-Shui Pan; Li Yan; Jing-Yu Fan; Ke He; Kai Sun; Yu-Ying Liu; Qing-Fang Chen; Yan Bai; Chuan-She Wang; Bing He; Ai-Ping Lv; Jing-Yan Han
Journal:  Sci Rep       Date:  2015-07-02       Impact factor: 4.379

6.  Short-term intravenous sodium nitrite infusion improves cardiac and pulmonary hemodynamics in heart failure patients.

Authors:  Julian O M Ormerod; Sayqa Arif; Majid Mukadam; Jonathan D W Evans; Roger Beadle; Bernadette O Fernandez; Robert S Bonser; Martin Feelisch; Melanie Madhani; Michael P Frenneaux
Journal:  Circ Heart Fail       Date:  2015-04-02       Impact factor: 8.790

7.  Effects of short-chain acyl-CoA dehydrogenase on cardiomyocyte apoptosis.

Authors:  Zhenhua Zeng; Qiuju Huang; Zhaohui Shu; Peiqing Liu; Shaorui Chen; Xuediao Pan; Linquan Zang; Sigui Zhou
Journal:  J Cell Mol Med       Date:  2016-03-17       Impact factor: 5.310

Review 8.  Present and future pharmacotherapeutic agents in heart failure: an evolving paradigm.

Authors:  Brodie L Loudon; Hannah Noordali; Nicholas D Gollop; Michael P Frenneaux; Melanie Madhani
Journal:  Br J Pharmacol       Date:  2016-05-06       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.